| GO:0051649 | establishment of localization in cell | 21.31% (26/122) | 2.39 | 0.0 | 0.0 |
| GO:0051641 | cellular localization | 24.59% (30/122) | 2.06 | 0.0 | 0.0 |
| GO:0046907 | intracellular transport | 18.85% (23/122) | 2.44 | 0.0 | 0.0 |
| GO:0032991 | protein-containing complex | 35.25% (43/122) | 1.51 | 0.0 | 0.0 |
| GO:0031323 | regulation of cellular metabolic process | 40.16% (49/122) | 1.3 | 0.0 | 0.0 |
| GO:0060255 | regulation of macromolecule metabolic process | 39.34% (48/122) | 1.32 | 0.0 | 0.0 |
| GO:0050794 | regulation of cellular process | 56.56% (69/122) | 0.95 | 0.0 | 0.0 |
| GO:0051171 | regulation of nitrogen compound metabolic process | 37.7% (46/122) | 1.37 | 0.0 | 0.0 |
| GO:0000390 | spliceosomal complex disassembly | 4.1% (5/122) | 7.06 | 0.0 | 0.0 |
| GO:0140513 | nuclear protein-containing complex | 18.85% (23/122) | 2.31 | 0.0 | 0.0 |
| GO:0019222 | regulation of metabolic process | 43.44% (53/122) | 1.18 | 0.0 | 0.0 |
| GO:0005515 | protein binding | 64.75% (79/122) | 0.77 | 0.0 | 0.0 |
| GO:0051640 | organelle localization | 11.48% (14/122) | 3.05 | 0.0 | 0.0 |
| GO:0019219 | regulation of nucleobase-containing compound metabolic process | 30.33% (37/122) | 1.49 | 0.0 | 1e-06 |
| GO:0080090 | regulation of primary metabolic process | 36.89% (45/122) | 1.25 | 0.0 | 1e-06 |
| GO:0032988 | ribonucleoprotein complex disassembly | 4.1% (5/122) | 6.19 | 0.0 | 1e-06 |
| GO:0016604 | nuclear body | 11.48% (14/122) | 2.73 | 0.0 | 4e-06 |
| GO:0010468 | regulation of gene expression | 31.97% (39/122) | 1.32 | 0.0 | 4e-06 |
| GO:0005654 | nucleoplasm | 18.03% (22/122) | 1.98 | 0.0 | 4e-06 |
| GO:0051179 | localization | 32.79% (40/122) | 1.3 | 0.0 | 5e-06 |
| GO:0043228 | non-membrane-bounded organelle | 25.41% (31/122) | 1.52 | 0.0 | 7e-06 |
| GO:0043232 | intracellular non-membrane-bounded organelle | 25.41% (31/122) | 1.52 | 0.0 | 7e-06 |
| GO:0050789 | regulation of biological process | 57.38% (70/122) | 0.77 | 0.0 | 7e-06 |
| GO:0006913 | nucleocytoplasmic transport | 7.38% (9/122) | 3.58 | 0.0 | 8e-06 |
| GO:0051169 | nuclear transport | 7.38% (9/122) | 3.57 | 0.0 | 9e-06 |
| GO:0048523 | negative regulation of cellular process | 28.69% (35/122) | 1.36 | 0.0 | 1.1e-05 |
| GO:0065007 | biological regulation | 59.84% (73/122) | 0.71 | 0.0 | 1.7e-05 |
| GO:0008104 | protein localization | 16.39% (20/122) | 1.94 | 0.0 | 2.3e-05 |
| GO:0048519 | negative regulation of biological process | 33.61% (41/122) | 1.13 | 0.0 | 3.9e-05 |
| GO:0071014 | post-mRNA release spliceosomal complex | 4.1% (5/122) | 5.06 | 0.0 | 3.9e-05 |
| GO:0005488 | binding | 72.13% (88/122) | 0.53 | 1e-06 | 4.9e-05 |
| GO:0006996 | organelle organization | 22.13% (27/122) | 1.5 | 1e-06 | 5.3e-05 |
| GO:0051252 | regulation of RNA metabolic process | 25.41% (31/122) | 1.36 | 1e-06 | 5.6e-05 |
| GO:0051234 | establishment of localization | 27.87% (34/122) | 1.26 | 1e-06 | 6.1e-05 |
| GO:0016043 | cellular component organization | 34.43% (42/122) | 1.08 | 1e-06 | 6.4e-05 |
| GO:0044877 | protein-containing complex binding | 12.3% (15/122) | 2.21 | 1e-06 | 6.8e-05 |
| GO:0051052 | regulation of DNA metabolic process | 9.02% (11/122) | 2.69 | 1e-06 | 8.9e-05 |
| GO:0070727 | cellular macromolecule localization | 16.39% (20/122) | 1.79 | 1e-06 | 9e-05 |
| GO:0045184 | establishment of protein localization | 13.11% (16/122) | 2.08 | 1e-06 | 9.1e-05 |
| GO:0005829 | cytosol | 31.15% (38/122) | 1.13 | 1e-06 | 9.9e-05 |
| GO:0033036 | macromolecule localization | 17.21% (21/122) | 1.7 | 2e-06 | 0.000113 |
| GO:0006886 | intracellular protein transport | 10.66% (13/122) | 2.33 | 2e-06 | 0.00013 |
| GO:0006810 | transport | 26.23% (32/122) | 1.24 | 3e-06 | 0.000161 |
| GO:0015031 | protein transport | 12.3% (15/122) | 2.08 | 3e-06 | 0.000173 |
| GO:0043170 | macromolecule metabolic process | 40.98% (50/122) | 0.87 | 3e-06 | 0.000186 |
| GO:0010948 | negative regulation of cell cycle process | 6.56% (8/122) | 3.16 | 4e-06 | 0.000206 |
| GO:0071008 | U2-type post-mRNA release spliceosomal complex | 2.46% (3/122) | 6.59 | 4e-06 | 0.000206 |
| GO:0071840 | cellular component organization or biogenesis | 34.43% (42/122) | 0.99 | 4e-06 | 0.000246 |
| GO:0051656 | establishment of organelle localization | 7.38% (9/122) | 2.86 | 5e-06 | 0.000258 |
| GO:0000386 | second spliceosomal transesterification activity | 2.46% (3/122) | 6.45 | 5e-06 | 0.00026 |
| GO:2001235 | positive regulation of apoptotic signaling pathway | 3.28% (4/122) | 5.08 | 6e-06 | 0.000326 |
| GO:0010605 | negative regulation of macromolecule metabolic process | 19.67% (24/122) | 1.43 | 7e-06 | 0.000349 |
| GO:1902494 | catalytic complex | 15.57% (19/122) | 1.68 | 7e-06 | 0.000351 |
| GO:0005681 | spliceosomal complex | 6.56% (8/122) | 3.03 | 7e-06 | 0.000351 |
| GO:0005684 | U2-type spliceosomal complex | 4.92% (6/122) | 3.63 | 1e-05 | 0.000407 |
| GO:0051107 | negative regulation of DNA ligation | 1.64% (2/122) | 8.32 | 1e-05 | 0.000409 |
| GO:0051352 | negative regulation of ligase activity | 1.64% (2/122) | 8.32 | 1e-05 | 0.000409 |
| GO:1904876 | negative regulation of DNA ligase activity | 1.64% (2/122) | 8.32 | 1e-05 | 0.000409 |
| GO:0004587 | ornithine-oxo-acid transaminase activity | 1.64% (2/122) | 8.32 | 1e-05 | 0.000409 |
| GO:0006593 | ornithine catabolic process | 1.64% (2/122) | 8.32 | 1e-05 | 0.000409 |
| GO:0010121 | arginine catabolic process to proline via ornithine | 1.64% (2/122) | 8.32 | 1e-05 | 0.000409 |
| GO:0019493 | arginine catabolic process to proline | 1.64% (2/122) | 8.32 | 1e-05 | 0.000409 |
| GO:0019544 | arginine catabolic process to glutamate | 1.64% (2/122) | 8.32 | 1e-05 | 0.000409 |
| GO:0050155 | ornithine(lysine) transaminase activity | 1.64% (2/122) | 8.32 | 1e-05 | 0.000409 |
| GO:0045786 | negative regulation of cell cycle | 6.56% (8/122) | 2.94 | 1.1e-05 | 0.000434 |
| GO:0071705 | nitrogen compound transport | 15.57% (19/122) | 1.65 | 9e-06 | 0.000446 |
| GO:0006282 | regulation of DNA repair | 4.92% (6/122) | 3.6 | 1.1e-05 | 0.000456 |
| GO:0009892 | negative regulation of metabolic process | 20.49% (25/122) | 1.35 | 1.2e-05 | 0.000488 |
| GO:0051172 | negative regulation of nitrogen compound metabolic process | 17.21% (21/122) | 1.51 | 1.3e-05 | 0.000524 |
| GO:0016607 | nuclear speck | 6.56% (8/122) | 2.88 | 1.5e-05 | 0.000562 |
| GO:0051129 | negative regulation of cellular component organization | 7.38% (9/122) | 2.65 | 1.5e-05 | 0.000566 |
| GO:0032984 | protein-containing complex disassembly | 4.92% (6/122) | 3.5 | 1.7e-05 | 0.000612 |
| GO:2001020 | regulation of response to DNA damage stimulus | 5.74% (7/122) | 3.14 | 1.6e-05 | 0.000616 |
| GO:1903047 | mitotic cell cycle process | 9.02% (11/122) | 2.27 | 1.9e-05 | 0.000694 |
| GO:0016192 | vesicle-mediated transport | 10.66% (13/122) | 2.02 | 2.1e-05 | 0.000746 |
| GO:0010639 | negative regulation of organelle organization | 5.74% (7/122) | 3.08 | 2.1e-05 | 0.000747 |
| GO:0010564 | regulation of cell cycle process | 9.02% (11/122) | 2.24 | 2.3e-05 | 0.000824 |
| GO:0005575 | cellular_component | 78.69% (96/122) | 0.37 | 2.4e-05 | 0.000831 |
| GO:0080135 | regulation of cellular response to stress | 9.02% (11/122) | 2.23 | 2.5e-05 | 0.000843 |
| GO:1904875 | regulation of DNA ligase activity | 1.64% (2/122) | 7.74 | 2.9e-05 | 0.000979 |
| GO:0051276 | chromosome organization | 7.38% (9/122) | 2.52 | 3.1e-05 | 0.001032 |
| GO:0009893 | positive regulation of metabolic process | 22.13% (27/122) | 1.2 | 3.2e-05 | 0.001059 |
| GO:1905818 | regulation of chromosome separation | 4.1% (5/122) | 3.78 | 3.5e-05 | 0.001127 |
| GO:0031324 | negative regulation of cellular metabolic process | 16.39% (20/122) | 1.46 | 3.5e-05 | 0.001135 |
| GO:0071702 | organic substance transport | 16.39% (20/122) | 1.46 | 3.6e-05 | 0.001149 |
| GO:0033365 | protein localization to organelle | 9.02% (11/122) | 2.17 | 3.7e-05 | 0.001158 |
| GO:0019899 | enzyme binding | 15.57% (19/122) | 1.51 | 3.7e-05 | 0.00116 |
| GO:0003674 | molecular_function | 77.05% (94/122) | 0.37 | 4.1e-05 | 0.001259 |
| GO:0048513 | animal organ development | 10.66% (13/122) | 1.91 | 4.5e-05 | 0.001359 |
| GO:0009968 | negative regulation of signal transduction | 11.48% (14/122) | 1.82 | 4.5e-05 | 0.00136 |
| GO:1990904 | ribonucleoprotein complex | 10.66% (13/122) | 1.9 | 4.9e-05 | 0.001443 |
| GO:0043393 | regulation of protein binding | 4.1% (5/122) | 3.67 | 4.9e-05 | 0.00145 |
| GO:0048518 | positive regulation of biological process | 31.97% (39/122) | 0.89 | 5.5e-05 | 0.00159 |
| GO:0031848 | protection from non-homologous end joining at telomere | 1.64% (2/122) | 7.32 | 5.8e-05 | 0.001663 |
| GO:0051173 | positive regulation of nitrogen compound metabolic process | 18.85% (23/122) | 1.28 | 6.1e-05 | 0.001752 |
| GO:0010648 | negative regulation of cell communication | 11.48% (14/122) | 1.77 | 6.5e-05 | 0.001797 |
| GO:0031326 | regulation of cellular biosynthetic process | 25.41% (31/122) | 1.04 | 6.5e-05 | 0.001801 |
| GO:0023057 | negative regulation of signaling | 11.48% (14/122) | 1.77 | 6.4e-05 | 0.001805 |
| GO:0051093 | negative regulation of developmental process | 10.66% (13/122) | 1.85 | 6.7e-05 | 0.001826 |
| GO:0022402 | cell cycle process | 12.3% (15/122) | 1.68 | 6.8e-05 | 0.001833 |
| GO:0010604 | positive regulation of macromolecule metabolic process | 19.67% (24/122) | 1.23 | 6.7e-05 | 0.001843 |
| GO:0051983 | regulation of chromosome segregation | 4.1% (5/122) | 3.56 | 7.1e-05 | 0.001844 |
| GO:1901987 | regulation of cell cycle phase transition | 6.56% (8/122) | 2.56 | 7e-05 | 0.001848 |
| GO:1901988 | negative regulation of cell cycle phase transition | 4.92% (6/122) | 3.13 | 7e-05 | 0.00185 |
| GO:0022411 | cellular component disassembly | 5.74% (7/122) | 2.79 | 7.6e-05 | 0.001964 |
| GO:0030029 | actin filament-based process | 4.92% (6/122) | 3.1 | 7.7e-05 | 0.001966 |
| GO:0006807 | nitrogen compound metabolic process | 44.26% (54/122) | 0.66 | 8.3e-05 | 0.002095 |
| GO:0008150 | biological_process | 77.87% (95/122) | 0.34 | 8.8e-05 | 0.00221 |
| GO:0048522 | positive regulation of cellular process | 27.05% (33/122) | 0.97 | 9e-05 | 0.002224 |
| GO:0043021 | ribonucleoprotein complex binding | 4.92% (6/122) | 3.06 | 9.1e-05 | 0.002243 |
| GO:0043247 | telomere maintenance in response to DNA damage | 1.64% (2/122) | 7.0 | 9.6e-05 | 0.00226 |
| GO:0051105 | regulation of DNA ligation | 1.64% (2/122) | 7.0 | 9.6e-05 | 0.00226 |
| GO:0051340 | regulation of ligase activity | 1.64% (2/122) | 7.0 | 9.6e-05 | 0.00226 |
| GO:0055129 | L-proline biosynthetic process | 1.64% (2/122) | 7.0 | 9.6e-05 | 0.00226 |
| GO:0071013 | catalytic step 2 spliceosome | 4.1% (5/122) | 3.48 | 9.3e-05 | 0.002263 |
| GO:1901990 | regulation of mitotic cell cycle phase transition | 5.74% (7/122) | 2.72 | 0.000101 | 0.002354 |
| GO:0005815 | microtubule organizing center | 6.56% (8/122) | 2.47 | 0.00011 | 0.002519 |
| GO:0051168 | nuclear export | 4.1% (5/122) | 3.43 | 0.000109 | 0.002521 |
| GO:0043933 | protein-containing complex organization | 12.3% (15/122) | 1.62 | 0.000112 | 0.002545 |
| GO:0009889 | regulation of biosynthetic process | 25.41% (31/122) | 0.99 | 0.000118 | 0.002653 |
| GO:0019538 | protein metabolic process | 26.23% (32/122) | 0.96 | 0.000125 | 0.002803 |
| GO:0043484 | regulation of RNA splicing | 4.92% (6/122) | 2.97 | 0.000129 | 0.002852 |
| GO:0071826 | ribonucleoprotein complex subunit organization | 5.74% (7/122) | 2.66 | 0.000132 | 0.002897 |
| GO:0051246 | regulation of protein metabolic process | 14.75% (18/122) | 1.41 | 0.000138 | 0.003002 |
| GO:0045595 | regulation of cell differentiation | 9.02% (11/122) | 1.95 | 0.000144 | 0.003056 |
| GO:0071021 | U2-type post-spliceosomal complex | 1.64% (2/122) | 6.74 | 0.000144 | 0.003064 |
| GO:0030101 | natural killer cell activation | 1.64% (2/122) | 6.74 | 0.000144 | 0.003064 |
| GO:0090304 | nucleic acid metabolic process | 18.85% (23/122) | 1.19 | 0.000148 | 0.003102 |
| GO:0097193 | intrinsic apoptotic signaling pathway | 3.28% (4/122) | 3.93 | 0.000144 | 0.003112 |
| GO:0045732 | positive regulation of protein catabolic process | 4.92% (6/122) | 2.93 | 0.00015 | 0.003117 |
| GO:0006606 | protein import into nucleus | 3.28% (4/122) | 3.9 | 0.000157 | 0.003252 |
| GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex | 2.46% (3/122) | 4.82 | 0.000165 | 0.003268 |
| GO:0000054 | ribosomal subunit export from nucleus | 2.46% (3/122) | 4.82 | 0.000165 | 0.003268 |
| GO:0033750 | ribosome localization | 2.46% (3/122) | 4.82 | 0.000165 | 0.003268 |
| GO:0007094 | mitotic spindle assembly checkpoint signaling | 2.46% (3/122) | 4.82 | 0.000165 | 0.003268 |
| GO:0006974 | cellular response to DNA damage stimulus | 9.02% (11/122) | 1.93 | 0.000162 | 0.003292 |
| GO:0008380 | RNA splicing | 5.74% (7/122) | 2.61 | 0.000161 | 0.003311 |
| GO:0043966 | histone H3 acetylation | 3.28% (4/122) | 3.86 | 0.000172 | 0.003374 |
| GO:0051726 | regulation of cell cycle | 9.84% (12/122) | 1.81 | 0.000177 | 0.003438 |
| GO:0010556 | regulation of macromolecule biosynthetic process | 22.13% (27/122) | 1.05 | 0.000178 | 0.003443 |
| GO:0030071 | regulation of mitotic metaphase/anaphase transition | 3.28% (4/122) | 3.85 | 0.00018 | 0.003449 |
| GO:0048585 | negative regulation of response to stimulus | 14.75% (18/122) | 1.37 | 0.000189 | 0.003612 |
| GO:0071173 | spindle assembly checkpoint signaling | 2.46% (3/122) | 4.74 | 0.000196 | 0.003719 |
| GO:0030852 | regulation of granulocyte differentiation | 1.64% (2/122) | 6.52 | 0.000201 | 0.003724 |
| GO:0030853 | negative regulation of granulocyte differentiation | 1.64% (2/122) | 6.52 | 0.000201 | 0.003724 |
| GO:0071020 | post-spliceosomal complex | 1.64% (2/122) | 6.52 | 0.000201 | 0.003724 |
| GO:0071174 | mitotic spindle checkpoint signaling | 2.46% (3/122) | 4.7 | 0.000213 | 0.003928 |
| GO:2001141 | regulation of RNA biosynthetic process | 19.67% (24/122) | 1.12 | 0.000215 | 0.003929 |
| GO:0072665 | protein localization to vacuole | 4.1% (5/122) | 3.2 | 0.000225 | 0.004081 |
| GO:0010965 | regulation of mitotic sister chromatid separation | 3.28% (4/122) | 3.75 | 0.000231 | 0.004086 |
| GO:2001251 | negative regulation of chromosome organization | 3.28% (4/122) | 3.75 | 0.000231 | 0.004086 |
| GO:0030695 | GTPase regulator activity | 4.1% (5/122) | 3.19 | 0.000231 | 0.004136 |
| GO:0060589 | nucleoside-triphosphatase regulator activity | 4.1% (5/122) | 3.19 | 0.000231 | 0.004136 |
| GO:0045596 | negative regulation of cell differentiation | 4.92% (6/122) | 2.8 | 0.000239 | 0.004206 |
| GO:0031577 | spindle checkpoint signaling | 2.46% (3/122) | 4.62 | 0.00025 | 0.004361 |
| GO:1901991 | negative regulation of mitotic cell cycle phase transition | 4.1% (5/122) | 3.16 | 0.000256 | 0.004444 |
| GO:0033046 | negative regulation of sister chromatid segregation | 2.46% (3/122) | 4.59 | 0.000269 | 0.004473 |
| GO:0033048 | negative regulation of mitotic sister chromatid segregation | 2.46% (3/122) | 4.59 | 0.000269 | 0.004473 |
| GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 2.46% (3/122) | 4.59 | 0.000269 | 0.004473 |
| GO:2000816 | negative regulation of mitotic sister chromatid separation | 2.46% (3/122) | 4.59 | 0.000269 | 0.004473 |
| GO:2001233 | regulation of apoptotic signaling pathway | 4.1% (5/122) | 3.14 | 0.000276 | 0.004536 |
| GO:0048856 | anatomical structure development | 33.61% (41/122) | 0.75 | 0.000276 | 0.004549 |
| GO:0002762 | negative regulation of myeloid leukocyte differentiation | 1.64% (2/122) | 6.32 | 0.000267 | 0.00455 |
| GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining | 1.64% (2/122) | 6.32 | 0.000267 | 0.00455 |
| GO:0006527 | arginine catabolic process | 1.64% (2/122) | 6.32 | 0.000267 | 0.00455 |
| GO:0010810 | regulation of cell-substrate adhesion | 2.46% (3/122) | 4.55 | 0.00029 | 0.004729 |
| GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 2.46% (3/122) | 4.52 | 0.000312 | 0.00502 |
| GO:1905819 | negative regulation of chromosome separation | 2.46% (3/122) | 4.52 | 0.000312 | 0.00502 |
| GO:0031152 | aggregation involved in sorocarp development | 2.46% (3/122) | 4.48 | 0.000334 | 0.005259 |
| GO:0045839 | negative regulation of mitotic nuclear division | 2.46% (3/122) | 4.48 | 0.000334 | 0.005259 |
| GO:2000819 | regulation of nucleotide-excision repair | 1.64% (2/122) | 6.15 | 0.000343 | 0.005304 |
| GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway | 1.64% (2/122) | 6.15 | 0.000343 | 0.005304 |
| GO:0060341 | regulation of cellular localization | 7.38% (9/122) | 2.06 | 0.000332 | 0.005312 |
| GO:0009896 | positive regulation of catabolic process | 6.56% (8/122) | 2.23 | 0.000334 | 0.005314 |
| GO:0051241 | negative regulation of multicellular organismal process | 9.02% (11/122) | 1.8 | 0.000342 | 0.005348 |
| GO:0097435 | supramolecular fiber organization | 5.74% (7/122) | 2.43 | 0.00035 | 0.00538 |
| GO:0043226 | organelle | 55.74% (68/122) | 0.47 | 0.000359 | 0.005497 |
| GO:0051985 | negative regulation of chromosome segregation | 2.46% (3/122) | 4.42 | 0.000382 | 0.005784 |
| GO:0042176 | regulation of protein catabolic process | 5.74% (7/122) | 2.41 | 0.000381 | 0.005794 |
| GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 3.28% (4/122) | 3.56 | 0.00039 | 0.005868 |
| GO:0006508 | proteolysis | 10.66% (13/122) | 1.59 | 0.000406 | 0.006038 |
| GO:0070603 | SWI/SNF superfamily-type complex | 3.28% (4/122) | 3.54 | 0.000404 | 0.006042 |
| GO:1902532 | negative regulation of intracellular signal transduction | 5.74% (7/122) | 2.39 | 0.000409 | 0.006045 |
| GO:0051603 | proteolysis involved in protein catabolic process | 8.2% (10/122) | 1.88 | 0.000411 | 0.006053 |
| GO:0051098 | regulation of binding | 4.92% (6/122) | 2.64 | 0.000429 | 0.006206 |
| GO:0034504 | protein localization to nucleus | 4.1% (5/122) | 2.99 | 0.000436 | 0.006207 |
| GO:0043971 | histone H3-K18 acetylation | 1.64% (2/122) | 6.0 | 0.000428 | 0.006225 |
| GO:0043972 | histone H3-K23 acetylation | 1.64% (2/122) | 6.0 | 0.000428 | 0.006225 |
| GO:0051170 | import into nucleus | 3.28% (4/122) | 3.52 | 0.000433 | 0.006228 |
| GO:0051879 | Hsp90 protein binding | 2.46% (3/122) | 4.35 | 0.000435 | 0.006232 |
| GO:0045930 | negative regulation of mitotic cell cycle | 4.1% (5/122) | 2.99 | 0.000446 | 0.006316 |
| GO:0033045 | regulation of sister chromatid segregation | 3.28% (4/122) | 3.49 | 0.000462 | 0.00652 |
| GO:0042752 | regulation of circadian rhythm | 4.1% (5/122) | 2.97 | 0.000466 | 0.006537 |
| GO:1902106 | negative regulation of leukocyte differentiation | 1.64% (2/122) | 5.86 | 0.000522 | 0.007026 |
| GO:1903707 | negative regulation of hemopoiesis | 1.64% (2/122) | 5.86 | 0.000522 | 0.007026 |
| GO:0000350 | generation of catalytic spliceosome for second transesterification step | 1.64% (2/122) | 5.86 | 0.000522 | 0.007026 |
| GO:0018394 | peptidyl-lysine acetylation | 4.1% (5/122) | 2.93 | 0.000532 | 0.007054 |
| GO:0006511 | ubiquitin-dependent protein catabolic process | 7.38% (9/122) | 1.97 | 0.000528 | 0.007069 |
| GO:0032880 | regulation of protein localization | 6.56% (8/122) | 2.13 | 0.000531 | 0.007086 |
| GO:0006475 | internal protein amino acid acetylation | 4.1% (5/122) | 2.94 | 0.00052 | 0.007112 |
| GO:0018393 | internal peptidyl-lysine acetylation | 4.1% (5/122) | 2.94 | 0.00052 | 0.007112 |
| GO:1903506 | regulation of nucleic acid-templated transcription | 18.85% (23/122) | 1.06 | 0.000539 | 0.007112 |
| GO:0036211 | protein modification process | 20.49% (25/122) | 1.01 | 0.000512 | 0.007113 |
| GO:0042981 | regulation of apoptotic process | 7.38% (9/122) | 1.97 | 0.000512 | 0.007149 |
| GO:0006355 | regulation of DNA-templated transcription | 18.85% (23/122) | 1.07 | 0.000518 | 0.00715 |
| GO:0072594 | establishment of protein localization to organelle | 5.74% (7/122) | 2.32 | 0.00055 | 0.007193 |
| GO:0019941 | modification-dependent protein catabolic process | 7.38% (9/122) | 1.96 | 0.000548 | 0.007205 |
| GO:0032092 | positive regulation of protein binding | 2.46% (3/122) | 4.24 | 0.000554 | 0.007207 |
| GO:0006915 | apoptotic process | 3.28% (4/122) | 3.42 | 0.000561 | 0.007268 |
| GO:0065009 | regulation of molecular function | 13.11% (16/122) | 1.34 | 0.000582 | 0.007428 |
| GO:0110165 | cellular anatomical entity | 74.59% (91/122) | 0.31 | 0.00058 | 0.007439 |
| GO:0004721 | phosphoprotein phosphatase activity | 4.1% (5/122) | 2.9 | 0.000579 | 0.007463 |
| GO:1902806 | regulation of cell cycle G1/S phase transition | 3.28% (4/122) | 3.39 | 0.000597 | 0.007589 |
| GO:0043065 | positive regulation of apoptotic process | 4.1% (5/122) | 2.88 | 0.000629 | 0.007962 |
| GO:0006259 | DNA metabolic process | 9.02% (11/122) | 1.69 | 0.000638 | 0.008037 |
| GO:0051128 | regulation of cellular component organization | 13.93% (17/122) | 1.26 | 0.000694 | 0.008698 |
| GO:0043632 | modification-dependent macromolecule catabolic process | 7.38% (9/122) | 1.91 | 0.000707 | 0.008817 |
| GO:0006473 | protein acetylation | 4.1% (5/122) | 2.83 | 0.000726 | 0.00901 |
| GO:0006470 | protein dephosphorylation | 4.1% (5/122) | 2.83 | 0.00074 | 0.009066 |
| GO:0010172 | embryonic body morphogenesis | 1.64% (2/122) | 5.62 | 0.000737 | 0.009067 |
| GO:0000055 | ribosomal large subunit export from nucleus | 1.64% (2/122) | 5.62 | 0.000737 | 0.009067 |
| GO:0031399 | regulation of protein modification process | 9.02% (11/122) | 1.66 | 0.000752 | 0.009164 |
| GO:0097190 | apoptotic signaling pathway | 3.28% (4/122) | 3.29 | 0.00078 | 0.009464 |
| GO:0040021 | hermaphrodite germ-line sex determination | 1.64% (2/122) | 5.52 | 0.000858 | 0.010054 |
| GO:0040022 | feminization of hermaphroditic germ-line | 1.64% (2/122) | 5.52 | 0.000858 | 0.010054 |
| GO:0035904 | aorta development | 1.64% (2/122) | 5.52 | 0.000858 | 0.010054 |
| GO:0033135 | regulation of peptidyl-serine phosphorylation | 2.46% (3/122) | 4.03 | 0.000849 | 0.010123 |
| GO:0033047 | regulation of mitotic sister chromatid segregation | 2.46% (3/122) | 4.03 | 0.000849 | 0.010123 |
| GO:0051784 | negative regulation of nuclear division | 2.46% (3/122) | 4.03 | 0.000849 | 0.010123 |
| GO:1904949 | ATPase complex | 3.28% (4/122) | 3.25 | 0.000872 | 0.010176 |
| GO:0030163 | protein catabolic process | 6.56% (8/122) | 2.02 | 0.000858 | 0.010181 |
| GO:0080008 | Cul4-RING E3 ubiquitin ligase complex | 3.28% (4/122) | 3.26 | 0.000848 | 0.010252 |
| GO:0044260 | cellular macromolecule metabolic process | 18.03% (22/122) | 1.04 | 0.000888 | 0.010317 |
| GO:0031325 | positive regulation of cellular metabolic process | 17.21% (21/122) | 1.06 | 0.001034 | 0.011807 |
| GO:0033554 | cellular response to stress | 18.85% (23/122) | 0.99 | 0.00103 | 0.011813 |
| GO:0009987 | cellular process | 66.39% (81/122) | 0.35 | 0.001042 | 0.011852 |
| GO:0007346 | regulation of mitotic cell cycle | 5.74% (7/122) | 2.16 | 0.001029 | 0.011853 |
| GO:0007088 | regulation of mitotic nuclear division | 3.28% (4/122) | 3.18 | 0.001025 | 0.011858 |
| GO:0043229 | intracellular organelle | 54.1% (66/122) | 0.44 | 0.001066 | 0.012078 |
| GO:0004722 | protein serine/threonine phosphatase activity | 3.28% (4/122) | 3.16 | 0.00108 | 0.01208 |
| GO:0007015 | actin filament organization | 3.28% (4/122) | 3.16 | 0.00108 | 0.01208 |
| GO:0006139 | nucleobase-containing compound metabolic process | 19.67% (24/122) | 0.96 | 0.001075 | 0.01212 |
| GO:0008154 | actin polymerization or depolymerization | 1.64% (2/122) | 5.32 | 0.001127 | 0.012249 |
| GO:0010171 | body morphogenesis | 1.64% (2/122) | 5.32 | 0.001127 | 0.012249 |
| GO:0060840 | artery development | 1.64% (2/122) | 5.32 | 0.001127 | 0.012249 |
| GO:1900024 | regulation of substrate adhesion-dependent cell spreading | 1.64% (2/122) | 5.32 | 0.001127 | 0.012249 |
| GO:0006591 | ornithine metabolic process | 1.64% (2/122) | 5.32 | 0.001127 | 0.012249 |
| GO:0007093 | mitotic cell cycle checkpoint signaling | 3.28% (4/122) | 3.15 | 0.001108 | 0.012293 |
| GO:0043412 | macromolecule modification | 22.13% (27/122) | 0.89 | 0.001106 | 0.012317 |
| GO:0031267 | small GTPase binding | 3.28% (4/122) | 3.12 | 0.001196 | 0.012948 |
| GO:0009966 | regulation of signal transduction | 15.57% (19/122) | 1.11 | 0.001217 | 0.013125 |
| GO:0006089 | lactate metabolic process | 1.64% (2/122) | 5.24 | 0.001274 | 0.013689 |
| GO:0005085 | guanyl-nucleotide exchange factor activity | 2.46% (3/122) | 3.82 | 0.001282 | 0.013719 |
| GO:0048232 | male gamete generation | 4.1% (5/122) | 2.65 | 0.001289 | 0.013734 |
| GO:1902531 | regulation of intracellular signal transduction | 8.2% (10/122) | 1.66 | 0.00135 | 0.014276 |
| GO:0009894 | regulation of catabolic process | 8.2% (10/122) | 1.66 | 0.00135 | 0.014276 |
| GO:0007276 | gamete generation | 4.92% (6/122) | 2.3 | 0.001453 | 0.015182 |
| GO:0046621 | negative regulation of organ growth | 2.46% (3/122) | 3.76 | 0.001452 | 0.015239 |
| GO:0006397 | mRNA processing | 5.74% (7/122) | 2.08 | 0.001451 | 0.015285 |
| GO:0042393 | histone binding | 4.1% (5/122) | 2.59 | 0.001525 | 0.015879 |
| GO:0009887 | animal organ morphogenesis | 4.1% (5/122) | 2.58 | 0.00155 | 0.01608 |
| GO:0008139 | nuclear localization sequence binding | 1.64% (2/122) | 5.08 | 0.001596 | 0.016425 |
| GO:0061608 | nuclear import signal receptor activity | 1.64% (2/122) | 5.08 | 0.001596 | 0.016425 |
| GO:0051248 | negative regulation of protein metabolic process | 7.38% (9/122) | 1.74 | 0.001625 | 0.016664 |
| GO:0050793 | regulation of developmental process | 20.49% (25/122) | 0.89 | 0.001689 | 0.017249 |
| GO:0035019 | somatic stem cell population maintenance | 1.64% (2/122) | 5.0 | 0.001769 | 0.017873 |
| GO:0051258 | protein polymerization | 2.46% (3/122) | 3.66 | 0.001766 | 0.017908 |
| GO:0043543 | protein acylation | 4.1% (5/122) | 2.54 | 0.001764 | 0.017951 |
| GO:0023052 | signaling | 3.28% (4/122) | 2.97 | 0.001786 | 0.017978 |
| GO:0010498 | proteasomal protein catabolic process | 5.74% (7/122) | 2.02 | 0.001807 | 0.018112 |
| GO:0051247 | positive regulation of protein metabolic process | 8.2% (10/122) | 1.6 | 0.001844 | 0.018416 |
| GO:0030036 | actin cytoskeleton organization | 3.28% (4/122) | 2.95 | 0.001867 | 0.018582 |
| GO:0140030 | modification-dependent protein binding | 3.28% (4/122) | 2.94 | 0.001908 | 0.018923 |
| GO:0002761 | regulation of myeloid leukocyte differentiation | 1.64% (2/122) | 4.93 | 0.001952 | 0.018937 |
| GO:0031011 | Ino80 complex | 1.64% (2/122) | 4.93 | 0.001952 | 0.018937 |
| GO:0031214 | biomineral tissue development | 1.64% (2/122) | 4.93 | 0.001952 | 0.018937 |
| GO:0110148 | biomineralization | 1.64% (2/122) | 4.93 | 0.001952 | 0.018937 |
| GO:0030234 | enzyme regulator activity | 7.38% (9/122) | 1.7 | 0.001941 | 0.019176 |
| GO:0007163 | establishment or maintenance of cell polarity | 3.28% (4/122) | 2.93 | 0.00195 | 0.019198 |
| GO:0032502 | developmental process | 39.34% (48/122) | 0.54 | 0.002028 | 0.019602 |
| GO:0018992 | germ-line sex determination | 1.64% (2/122) | 4.86 | 0.002143 | 0.020567 |
| GO:0044154 | histone H3-K14 acetylation | 1.64% (2/122) | 4.86 | 0.002143 | 0.020567 |
| GO:1990234 | transferase complex | 8.2% (10/122) | 1.56 | 0.002155 | 0.020609 |
| GO:0044265 | cellular macromolecule catabolic process | 8.2% (10/122) | 1.56 | 0.002183 | 0.020739 |
| GO:0071005 | U2-type precatalytic spliceosome | 2.46% (3/122) | 3.55 | 0.002195 | 0.020776 |
| GO:0042325 | regulation of phosphorylation | 5.74% (7/122) | 1.97 | 0.002183 | 0.020811 |
| GO:0030155 | regulation of cell adhesion | 3.28% (4/122) | 2.88 | 0.002215 | 0.020893 |
| GO:0051646 | mitochondrion localization | 2.46% (3/122) | 3.53 | 0.002272 | 0.021357 |
| GO:0003281 | ventricular septum development | 1.64% (2/122) | 4.8 | 0.002342 | 0.021859 |
| GO:0010385 | double-stranded methylated DNA binding | 1.64% (2/122) | 4.8 | 0.002342 | 0.021859 |
| GO:0019220 | regulation of phosphate metabolic process | 6.56% (8/122) | 1.78 | 0.002428 | 0.022586 |
| GO:0050790 | regulation of catalytic activity | 9.02% (11/122) | 1.45 | 0.002462 | 0.022749 |
| GO:0000075 | cell cycle checkpoint signaling | 3.28% (4/122) | 2.84 | 0.002454 | 0.022749 |
| GO:0043067 | regulation of programmed cell death | 8.2% (10/122) | 1.54 | 0.002474 | 0.022781 |
| GO:0031625 | ubiquitin protein ligase binding | 4.92% (6/122) | 2.14 | 0.002508 | 0.022863 |
| GO:0042802 | identical protein binding | 15.57% (19/122) | 1.02 | 0.002502 | 0.022884 |
| GO:0033044 | regulation of chromosome organization | 4.1% (5/122) | 2.43 | 0.002498 | 0.022921 |
| GO:0031034 | myosin filament assembly | 1.64% (2/122) | 4.74 | 0.002549 | 0.022928 |
| GO:0030864 | cortical actin cytoskeleton | 1.64% (2/122) | 4.74 | 0.002549 | 0.022928 |
| GO:2000780 | negative regulation of double-strand break repair | 1.64% (2/122) | 4.74 | 0.002549 | 0.022928 |
| GO:0005856 | cytoskeleton | 5.74% (7/122) | 1.93 | 0.002546 | 0.023123 |
| GO:0033043 | regulation of organelle organization | 7.38% (9/122) | 1.63 | 0.002606 | 0.02328 |
| GO:0051020 | GTPase binding | 3.28% (4/122) | 2.82 | 0.002605 | 0.023353 |
| GO:0051174 | regulation of phosphorus metabolic process | 6.56% (8/122) | 1.76 | 0.002677 | 0.023834 |
| GO:0045638 | negative regulation of myeloid cell differentiation | 1.64% (2/122) | 4.68 | 0.002766 | 0.024306 |
| GO:0031033 | myosin filament organization | 1.64% (2/122) | 4.68 | 0.002766 | 0.024306 |
| GO:0031053 | primary miRNA processing | 1.64% (2/122) | 4.68 | 0.002766 | 0.024306 |
| GO:0051716 | cellular response to stimulus | 24.59% (30/122) | 0.74 | 0.00278 | 0.024356 |
| GO:0042127 | regulation of cell population proliferation | 7.38% (9/122) | 1.62 | 0.002758 | 0.02448 |
| GO:0023051 | regulation of signaling | 15.57% (19/122) | 1.0 | 0.002815 | 0.02458 |
| GO:0044389 | ubiquitin-like protein ligase binding | 4.92% (6/122) | 2.08 | 0.003129 | 0.025211 |
| GO:0018205 | peptidyl-lysine modification | 4.92% (6/122) | 2.08 | 0.003129 | 0.025211 |
| GO:0006058 | mannoprotein catabolic process | 0.82% (1/122) | 8.32 | 0.003121 | 0.025296 |
| GO:0043149 | stress fiber assembly | 0.82% (1/122) | 8.32 | 0.003121 | 0.025296 |
| GO:0030043 | actin filament fragmentation | 0.82% (1/122) | 8.32 | 0.003121 | 0.025296 |
| GO:0042247 | establishment of planar polarity of follicular epithelium | 0.82% (1/122) | 8.32 | 0.003121 | 0.025296 |
| GO:0045214 | sarcomere organization | 0.82% (1/122) | 8.32 | 0.003121 | 0.025296 |
| GO:1903673 | mitotic cleavage furrow formation | 0.82% (1/122) | 8.32 | 0.003121 | 0.025296 |
| GO:1905861 | intranuclear rod assembly | 0.82% (1/122) | 8.32 | 0.003121 | 0.025296 |
| GO:0071818 | BAT3 complex | 0.82% (1/122) | 8.32 | 0.003121 | 0.025296 |
| GO:0106070 | regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway | 0.82% (1/122) | 8.32 | 0.003121 | 0.025296 |
| GO:0061463 | O-acetyl-ADP-ribose deacetylase activity | 0.82% (1/122) | 8.32 | 0.003121 | 0.025296 |
| GO:1904672 | regulation of somatic stem cell population maintenance | 0.82% (1/122) | 8.32 | 0.003121 | 0.025296 |
| GO:0002724 | regulation of T cell cytokine production | 0.82% (1/122) | 8.32 | 0.003121 | 0.025296 |
| GO:0002726 | positive regulation of T cell cytokine production | 0.82% (1/122) | 8.32 | 0.003121 | 0.025296 |
| GO:2000551 | regulation of T-helper 2 cell cytokine production | 0.82% (1/122) | 8.32 | 0.003121 | 0.025296 |
| GO:2000553 | positive regulation of T-helper 2 cell cytokine production | 0.82% (1/122) | 8.32 | 0.003121 | 0.025296 |
| GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway | 0.82% (1/122) | 8.32 | 0.003121 | 0.025296 |
| GO:0050860 | negative regulation of T cell receptor signaling pathway | 0.82% (1/122) | 8.32 | 0.003121 | 0.025296 |
| GO:0000378 | RNA exon ligation | 0.82% (1/122) | 8.32 | 0.003121 | 0.025296 |
| GO:0000151 | ubiquitin ligase complex | 4.92% (6/122) | 2.08 | 0.003163 | 0.025333 |
| GO:0031072 | heat shock protein binding | 3.28% (4/122) | 2.74 | 0.003157 | 0.025355 |
| GO:0140096 | catalytic activity, acting on a protein | 18.85% (23/122) | 0.87 | 0.00324 | 0.025421 |
| GO:0071011 | precatalytic spliceosome | 2.46% (3/122) | 3.35 | 0.003234 | 0.025445 |
| GO:0031048 | small non-coding RNA-dependent heterochromatin formation | 2.46% (3/122) | 3.35 | 0.003234 | 0.025445 |
| GO:0071712 | ER-associated misfolded protein catabolic process | 1.64% (2/122) | 4.57 | 0.003223 | 0.025507 |
| GO:0048736 | appendage development | 1.64% (2/122) | 4.57 | 0.003223 | 0.025507 |
| GO:0045738 | negative regulation of DNA repair | 1.64% (2/122) | 4.57 | 0.003223 | 0.025507 |
| GO:0009065 | glutamine family amino acid catabolic process | 1.64% (2/122) | 4.57 | 0.003223 | 0.025507 |
| GO:1902936 | phosphatidylinositol bisphosphate binding | 2.46% (3/122) | 3.4 | 0.00295 | 0.025682 |
| GO:0140142 | nucleocytoplasmic carrier activity | 1.64% (2/122) | 4.62 | 0.00299 | 0.025776 |
| GO:0000145 | exocyst | 1.64% (2/122) | 4.62 | 0.00299 | 0.025776 |
| GO:0002429 | immune response-activating cell surface receptor signaling pathway | 1.64% (2/122) | 4.62 | 0.00299 | 0.025776 |
| GO:1903076 | regulation of protein localization to plasma membrane | 2.46% (3/122) | 3.34 | 0.003331 | 0.026064 |
| GO:0010646 | regulation of cell communication | 15.57% (19/122) | 0.99 | 0.003048 | 0.026114 |
| GO:2000779 | regulation of double-strand break repair | 2.46% (3/122) | 3.39 | 0.003043 | 0.026151 |
| GO:0046578 | regulation of Ras protein signal transduction | 2.46% (3/122) | 3.32 | 0.003431 | 0.026767 |
| GO:0035459 | vesicle cargo loading | 1.64% (2/122) | 4.52 | 0.003463 | 0.026786 |
| GO:2001032 | regulation of double-strand break repair via nonhomologous end joining | 1.64% (2/122) | 4.52 | 0.003463 | 0.026786 |
| GO:0003279 | cardiac septum development | 1.64% (2/122) | 4.52 | 0.003463 | 0.026786 |
| GO:0065003 | protein-containing complex assembly | 9.02% (11/122) | 1.37 | 0.003633 | 0.028016 |
| GO:0016581 | NuRD complex | 1.64% (2/122) | 4.47 | 0.003712 | 0.028468 |
| GO:0090545 | CHD-type complex | 1.64% (2/122) | 4.47 | 0.003712 | 0.028468 |
| GO:0051056 | regulation of small GTPase mediated signal transduction | 2.46% (3/122) | 3.28 | 0.003741 | 0.028609 |
| GO:0005635 | nuclear envelope | 3.28% (4/122) | 2.67 | 0.003782 | 0.02868 |
| GO:0051783 | regulation of nuclear division | 3.28% (4/122) | 2.67 | 0.003782 | 0.02868 |
| GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 9.84% (12/122) | 1.29 | 0.003781 | 0.028835 |
| GO:0042632 | cholesterol homeostasis | 1.64% (2/122) | 4.42 | 0.003969 | 0.029683 |
| GO:0001667 | ameboidal-type cell migration | 1.64% (2/122) | 4.42 | 0.003969 | 0.029683 |
| GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 1.64% (2/122) | 4.42 | 0.003969 | 0.029683 |
| GO:1903077 | negative regulation of protein localization to plasma membrane | 1.64% (2/122) | 4.42 | 0.003969 | 0.029683 |
| GO:1904376 | negative regulation of protein localization to cell periphery | 1.64% (2/122) | 4.42 | 0.003969 | 0.029683 |
| GO:0051239 | regulation of multicellular organismal process | 15.57% (19/122) | 0.96 | 0.003984 | 0.029713 |
| GO:0016573 | histone acetylation | 3.28% (4/122) | 2.64 | 0.004055 | 0.030153 |
| GO:2000001 | regulation of DNA damage checkpoint | 1.64% (2/122) | 4.37 | 0.004235 | 0.031405 |
| GO:0043022 | ribosome binding | 2.46% (3/122) | 3.21 | 0.004295 | 0.031593 |
| GO:1904375 | regulation of protein localization to cell periphery | 2.46% (3/122) | 3.21 | 0.004295 | 0.031593 |
| GO:0099023 | vesicle tethering complex | 2.46% (3/122) | 3.21 | 0.004295 | 0.031593 |
| GO:0044248 | cellular catabolic process | 13.93% (17/122) | 1.01 | 0.004331 | 0.031684 |
| GO:0046483 | heterocycle metabolic process | 22.13% (27/122) | 0.75 | 0.00432 | 0.031691 |
| GO:0042254 | ribosome biogenesis | 2.46% (3/122) | 3.19 | 0.004411 | 0.0321 |
| GO:0007423 | sensory organ development | 2.46% (3/122) | 3.19 | 0.004411 | 0.0321 |
| GO:0048598 | embryonic morphogenesis | 4.1% (5/122) | 2.23 | 0.004429 | 0.032142 |
| GO:0097346 | INO80-type complex | 1.64% (2/122) | 4.32 | 0.004508 | 0.032281 |
| GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 1.64% (2/122) | 4.32 | 0.004508 | 0.032281 |
| GO:2001236 | regulation of extrinsic apoptotic signaling pathway | 1.64% (2/122) | 4.32 | 0.004508 | 0.032281 |
| GO:0000109 | nucleotide-excision repair complex | 1.64% (2/122) | 4.32 | 0.004508 | 0.032281 |
| GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 2.46% (3/122) | 3.18 | 0.00453 | 0.032352 |
| GO:0003676 | nucleic acid binding | 23.77% (29/122) | 0.71 | 0.004542 | 0.032359 |
| GO:0022607 | cellular component assembly | 13.11% (16/122) | 1.05 | 0.00449 | 0.032498 |
| GO:0006281 | DNA repair | 5.74% (7/122) | 1.77 | 0.004625 | 0.032864 |
| GO:0140535 | intracellular protein-containing complex | 7.38% (9/122) | 1.51 | 0.004646 | 0.032923 |
| GO:0001932 | regulation of protein phosphorylation | 4.92% (6/122) | 1.96 | 0.004661 | 0.032946 |
| GO:0044238 | primary metabolic process | 43.44% (53/122) | 0.45 | 0.004736 | 0.033386 |
| GO:0006525 | arginine metabolic process | 1.64% (2/122) | 4.28 | 0.004789 | 0.03367 |
| GO:0051960 | regulation of nervous system development | 3.28% (4/122) | 2.56 | 0.00495 | 0.034716 |
| GO:0043230 | extracellular organelle | 2.46% (3/122) | 3.13 | 0.005022 | 0.034856 |
| GO:0065010 | extracellular membrane-bounded organelle | 2.46% (3/122) | 3.13 | 0.005022 | 0.034856 |
| GO:0007010 | cytoskeleton organization | 6.56% (8/122) | 1.61 | 0.004987 | 0.034885 |
| GO:0099080 | supramolecular complex | 7.38% (9/122) | 1.49 | 0.005009 | 0.034948 |
| GO:0010811 | positive regulation of cell-substrate adhesion | 1.64% (2/122) | 4.24 | 0.005078 | 0.035154 |
| GO:1901565 | organonitrogen compound catabolic process | 8.2% (10/122) | 1.38 | 0.005194 | 0.035865 |
| GO:0046580 | negative regulation of Ras protein signal transduction | 1.64% (2/122) | 4.19 | 0.005374 | 0.036926 |
| GO:0006561 | proline biosynthetic process | 1.64% (2/122) | 4.19 | 0.005374 | 0.036926 |
| GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 4.92% (6/122) | 1.91 | 0.005428 | 0.037198 |
| GO:0007283 | spermatogenesis | 3.28% (4/122) | 2.52 | 0.005444 | 0.037216 |
| GO:0035556 | intracellular signal transduction | 8.2% (10/122) | 1.37 | 0.005644 | 0.038482 |
| GO:0006888 | endoplasmic reticulum to Golgi vesicle-mediated transport | 2.46% (3/122) | 3.06 | 0.005681 | 0.03854 |
| GO:0051058 | negative regulation of small GTPase mediated signal transduction | 1.64% (2/122) | 4.15 | 0.005679 | 0.038626 |
| GO:2001256 | regulation of store-operated calcium entry | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:0031257 | cell trailing edge membrane | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:0036052 | protein localization to uropod | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:0048854 | brain morphogenesis | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:0106017 | phosphatidylinositol-3,4-bisphosphate phosphatase activity | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:0043297 | apical junction assembly | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:0036506 | maintenance of unfolded protein | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:1904378 | maintenance of unfolded protein involved in ERAD pathway | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:0003157 | endocardium development | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:0060800 | regulation of cell differentiation involved in embryonic placenta development | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:0090168 | Golgi reassembly | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:1904235 | regulation of substrate-dependent cell migration, cell attachment to substrate | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:1904237 | positive regulation of substrate-dependent cell migration, cell attachment to substrate | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:0035874 | cellular response to copper ion starvation | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:0120126 | response to copper ion starvation | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:1904751 | positive regulation of protein localization to nucleolus | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:0004459 | L-lactate dehydrogenase activity | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:0019244 | lactate biosynthetic process from pyruvate | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:0019659 | glucose catabolic process to lactate | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:0019661 | glucose catabolic process to lactate via pyruvate | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:0003992 | N2-acetyl-L-ornithine:2-oxoglutarate 5-aminotransferase activity | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:0018900 | dichloromethane metabolic process | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:0047651 | alkylhalidase activity | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading | 0.82% (1/122) | 7.32 | 0.006233 | 0.038875 |
| GO:0070647 | protein modification by small protein conjugation or removal | 8.2% (10/122) | 1.35 | 0.006257 | 0.038937 |
| GO:0009057 | macromolecule catabolic process | 9.02% (11/122) | 1.27 | 0.006279 | 0.038986 |
| GO:0055092 | sterol homeostasis | 1.64% (2/122) | 4.08 | 0.006311 | 0.039007 |
| GO:0030863 | cortical cytoskeleton | 1.64% (2/122) | 4.08 | 0.006311 | 0.039007 |
| GO:0048583 | regulation of response to stimulus | 22.13% (27/122) | 0.71 | 0.006332 | 0.039045 |
| GO:1901564 | organonitrogen compound metabolic process | 31.97% (39/122) | 0.55 | 0.005813 | 0.039341 |
| GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle | 1.64% (2/122) | 4.11 | 0.005991 | 0.040046 |
| GO:0010256 | endomembrane system organization | 1.64% (2/122) | 4.11 | 0.005991 | 0.040046 |
| GO:0000380 | alternative mRNA splicing, via spliceosome | 1.64% (2/122) | 4.11 | 0.005991 | 0.040046 |
| GO:0001568 | blood vessel development | 1.64% (2/122) | 4.11 | 0.005991 | 0.040046 |
| GO:0042054 | histone methyltransferase activity | 2.46% (3/122) | 3.04 | 0.005958 | 0.040221 |
| GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.64% (2/122) | 4.04 | 0.006639 | 0.04066 |
| GO:0031032 | actomyosin structure organization | 1.64% (2/122) | 4.04 | 0.006639 | 0.04066 |
| GO:0004402 | histone acetyltransferase activity | 1.64% (2/122) | 4.04 | 0.006639 | 0.04066 |
| GO:0006515 | protein quality control for misfolded or incompletely synthesized proteins | 2.46% (3/122) | 3.03 | 0.0061 | 0.04067 |
| GO:0098772 | molecular function regulator activity | 7.38% (9/122) | 1.42 | 0.006688 | 0.040776 |
| GO:0006396 | RNA processing | 9.84% (12/122) | 1.19 | 0.006678 | 0.040807 |
| GO:0048193 | Golgi vesicle transport | 4.1% (5/122) | 2.11 | 0.006219 | 0.041362 |
| GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 3.28% (4/122) | 2.42 | 0.006821 | 0.041492 |
| GO:0046620 | regulation of organ growth | 2.46% (3/122) | 2.97 | 0.006838 | 0.041505 |
| GO:0034641 | cellular nitrogen compound metabolic process | 22.13% (27/122) | 0.7 | 0.006909 | 0.041838 |
| GO:0061062 | regulation of nematode larval development | 1.64% (2/122) | 4.0 | 0.006974 | 0.041861 |
| GO:0007530 | sex determination | 1.64% (2/122) | 4.0 | 0.006974 | 0.041861 |
| GO:0006560 | proline metabolic process | 1.64% (2/122) | 4.0 | 0.006974 | 0.041861 |
| GO:0061733 | peptide-lysine-N-acetyltransferase activity | 1.64% (2/122) | 4.0 | 0.006974 | 0.041861 |
| GO:0009056 | catabolic process | 15.57% (19/122) | 0.87 | 0.007323 | 0.043473 |
| GO:0043327 | chemotaxis to cAMP | 1.64% (2/122) | 3.97 | 0.007317 | 0.043533 |
| GO:0051896 | regulation of protein kinase B signaling | 1.64% (2/122) | 3.97 | 0.007317 | 0.043533 |
| GO:0006907 | pinocytosis | 1.64% (2/122) | 3.97 | 0.007317 | 0.043533 |
| GO:0032527 | protein exit from endoplasmic reticulum | 1.64% (2/122) | 3.97 | 0.007317 | 0.043533 |
| GO:0000375 | RNA splicing, via transesterification reactions | 3.28% (4/122) | 2.39 | 0.00743 | 0.043821 |
| GO:0031647 | regulation of protein stability | 4.1% (5/122) | 2.05 | 0.007399 | 0.043825 |
| GO:0032446 | protein modification by small protein conjugation | 7.38% (9/122) | 1.4 | 0.007419 | 0.043848 |
| GO:1905475 | regulation of protein localization to membrane | 2.46% (3/122) | 2.92 | 0.007466 | 0.043935 |
| GO:0071496 | cellular response to external stimulus | 7.38% (9/122) | 1.39 | 0.007589 | 0.044563 |
| GO:0031400 | negative regulation of protein modification process | 4.1% (5/122) | 2.04 | 0.007636 | 0.044742 |
| GO:1905476 | negative regulation of protein localization to membrane | 1.64% (2/122) | 3.93 | 0.007667 | 0.044828 |
| GO:0016311 | dephosphorylation | 4.1% (5/122) | 2.03 | 0.007961 | 0.046444 |
| GO:1901976 | regulation of cell cycle checkpoint | 1.64% (2/122) | 3.9 | 0.008025 | 0.046718 |
| GO:0006623 | protein targeting to vacuole | 2.46% (3/122) | 2.86 | 0.008297 | 0.048093 |
| GO:0010941 | regulation of cell death | 8.2% (10/122) | 1.28 | 0.008287 | 0.048141 |
| GO:0031514 | motile cilium | 1.64% (2/122) | 3.86 | 0.00839 | 0.048324 |
| GO:0005643 | nuclear pore | 1.64% (2/122) | 3.86 | 0.00839 | 0.048324 |
| GO:0031288 | sorocarp morphogenesis | 1.64% (2/122) | 3.86 | 0.00839 | 0.048324 |
| GO:0043254 | regulation of protein-containing complex assembly | 3.28% (4/122) | 2.34 | 0.00841 | 0.048336 |
| GO:0036464 | cytoplasmic ribonucleoprotein granule | 4.1% (5/122) | 2.01 | 0.008466 | 0.048552 |
| GO:0051130 | positive regulation of cellular component organization | 5.74% (7/122) | 1.61 | 0.008484 | 0.048553 |
| GO:0048708 | astrocyte differentiation | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:0050923 | regulation of negative chemotaxis | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:1900122 | positive regulation of receptor binding | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:1903035 | negative regulation of response to wounding | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:1903667 | regulation of chemorepellent activity | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:1903669 | positive regulation of chemorepellent activity | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:1903551 | regulation of extracellular exosome assembly | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:1903553 | positive regulation of extracellular exosome assembly | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:0002446 | neutrophil mediated immunity | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:0072379 | ER membrane insertion complex | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:0004416 | hydroxyacylglutathione hydrolase activity | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:0048644 | muscle organ morphogenesis | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:0002828 | regulation of type 2 immune response | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:0002830 | positive regulation of type 2 immune response | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:0003373 | dynamin family protein polymerization involved in membrane fission | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:0003374 | dynamin family protein polymerization involved in mitochondrial fission | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:0051433 | BH2 domain binding | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:0090649 | response to oxygen-glucose deprivation | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:0090650 | cellular response to oxygen-glucose deprivation | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:1905395 | response to flavonoid | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:1990910 | response to hypobaric hypoxia | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:2000302 | positive regulation of synaptic vesicle exocytosis | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:0048211 | Golgi vesicle docking | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:0003170 | heart valve development | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:0060708 | spongiotrophoblast differentiation | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:0010812 | negative regulation of cell-substrate adhesion | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:1990423 | RZZ complex | 0.82% (1/122) | 6.74 | 0.009335 | 0.049644 |
| GO:0031593 | polyubiquitin modification-dependent protein binding | 1.64% (2/122) | 3.83 | 0.008763 | 0.049938 |
| GO:0006310 | DNA recombination | 3.28% (4/122) | 2.32 | 0.008755 | 0.049998 |